SastaSundar looking to raise USD 100 million in Series D funding round
Category: #business |   By Hrishikesh Kadam |   Date: 2021-05-11

SastaSundar looking to raise USD 100 million in Series D funding round

SastaSundar, an Indian digital healthcare and wellness products startup, is reportedly in talks with Rohto Pharmaceuticals Co., Mitsubishi Corp., and other private investors to raise around USD 100 million as a part of its Series D funding round.

The company is planning to invest around USD 25 million during 2021 itself to branch out its services in India amid the lethal second wave of the coronavirus pandemic, according to sources.

SastaSundar will reportedly utilize a part of the upcoming funding proceeds to expand its network of high-quality diagnostic centers, labeled Genu Path Labs, which will help facilitate the national Covid-19 vaccination drive.

The company will also use the funds to scale its primary online medicine sales business, across India, especially considering the 50% surge in demand for preventive medicines such as cough syrups and paracetamols in Tier-2/3 towns and villages.

Founder and Executive Chairman of SastaSundar, BL Mittal, was quoted saying that the company’s diagnostic centers will conduct RT-PCR testing for detection of Covid-19 cases while also offering customized vaccinations once the vaccine supplies resume to normal.

It is worth noting that SastaSundar had previously raised around USD 24 million from its two Japanese investors, Rohto Pharmaceuticals Co., and Mitsubishi Corp who collectively hold 28% stake in the company, while the majority 72% stake is held by the holding company, SastaSundar Ventures.

The previous funding round had marked the organization’s valuation at roughly USD 110 million. The company is now looking to raise the aforementioned USD 100 million within 2 years, cited knowledgeable sources.

The e-healthcare startup is also eyeing to lengthen its chain of physical counseling and service centers, named Healthbuddies, where, people unfamiliar with technology, particularly senior citizens, can physically visit and place orders for medicines that are then home delivered.

Source Link –

https://telecom.economictimes.indiatimes.com/news/sastasundar-com-in-talks-to-raise-around-100-million/82513292

 

  • shareShare
  • Twitter
  • Facebook
  • LinkedIn


About Author

Hrishikesh Kadam     Twitter

Hrishikesh Kadam

A graduate in electronics and telecommunication engineering, Hrishikesh Kadam has always found writing fascinating. Driven by a never-ending passion for content creation combined with a bit of experience in writing personal blogs, Hrishikesh blends his technical knowl Read more...

More News By Hrishikesh Kadam

Cloud solution provider Cloopen to acquire Zhuge in cash & stock deal

Cloud solution provider Cloopen to acquire Zhuge in cash & stock deal

By Hrishikesh Kadam

Cloopen Group Holding Limited, one of China’s leading multi-capability cloud-based communications solution providers, has announced that it has made a definitive agreement to purchase complete equity interests in Zhuge Inc., a provider of user-...

Sense raises USD 90 Mn in Series D to expand its HR tech offerings

Sense raises USD 90 Mn in Series D to expand its HR tech offerings

By Hrishikesh Kadam

HR tech firm Sense has multiplied its valuation to USD 500 million in its 50 million Series D fundraise, spearheaded by SoftBank Vision Fund. The five-and-a-half-year-old San Francisco-based startup, which caters to blue-collar workers and assists co...

Mazda Australia faces heat over misleading customers seeking refunds

Mazda Australia faces heat over misleading customers seeking refunds

By Hrishikesh Kadam

The court identified Mazda made 49 distinct fraudulent or misleading representations to nine consumers who sought a refund or replacement of their cars. Australian Competition and Consumer Commission (ACCC) initially filed the case against Mazda, ...